Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions.

Phase 4CompletedNCT00764387

Bayer166 enrolled

Overview

Study to compare of two contrast agents in imaging brain lesions.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

DIAGNOSTIC

Masking

SINGLE

Enrollment

166

0,1 mmol/kg of body weight in the vein, single administration

0,1 mmol/kg of body weight in the vein, single administration

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Known neoplastic CNS lesions

Unnamed facility

Andria, Bari, Italy

Unnamed facility

Catania, Italy

Unnamed facility

Chieti, Italy

Unnamed facility

Messina, Italy

The primary analysis will be the comparison of the enhancements characteristics of Gadobutrol and Gd-TOTA on a lesion per lesion basis.

Time frame: October 2007 to November 2008

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.